Oncology and Hematology - Clinical Practice - Prova Education

Episodes 17-32 of 53

- Mark A. Socinski, MD
  Peer
2
CME/CE
0.25 credits
Key Highlights from the Latest Clinical Trials in Lung Cancer
0.25 credits
- Mark A. Socinski, MD
  Peer
- Tarek M. Mekhail, MD, MSC, FRCSI, FRCSEd
  Peer
12
CME/CE
0.25 credits
Insights from the Latest Clinical Trials in Lung Cancer
0.25 credits
- William Mencia, MD, FACEHP, CHCP
  Peer
- Roy F. Chemaly, MD, MPH, FIDSA, FACP
  Peer
15
CME/CE
0.25 credits
Combating CMV in HCT Recipients: A New Era of Therapy
0.25 credits
- Paul Oberstein, MD
  Peer
- Eileen M. O'Reilly, MD
  Peer
2
CME/CE
0.25 credits
Gastrointestinal Cancer: Exploring the Latest Studies
0.25 credits
- Rachel Caskey, MD, MAPP
  Peer
5
CME/CE
0.25 credits
Conquering HPV Vaccine Hesitancy in Your Clinical Practice
0.25 credits
- Paul Oberstein, MD
  Peer
- Eileen M. O'Reilly, MD
  Peer
9
CME/CE
0.25 credits
Advancing Care in Gastrointestinal Cancers
0.25 credits
- Warner K. Huh, MD
  Peer
4
CME/CE
0.25 credits
The Success Story That Is HPV Vaccination
0.25 credits
- William D. Tap, MD
  Peer
- Silvia Stacchiotti, MD
  Peer
- Michiel van de Sande, MD, PhD
  Peer
- Andrew J. Wagner, MD, PhD
  Peer
6
CME/CE
0.25 credits
Improving Clinical Practices in the Management of Tenosynovial Giant Cell Tum...
0.25 credits
- Rachel Caskey, MD, MAPP
  Peer
10
CME/CE
0.25 credits
Vaccine Hesitancy with a Focus on HPV
0.25 credits
- William D. Tap, MD
  Peer
- Silvia Stacchiotti, MD
  Peer
- Michiel van de Sande, MD, PhD
  Peer
- Andrew J. Wagner, MD, PhD
  Peer
9
CME/CE
0.25 credits
Tenosynovial Giant Cell Tumor (TGCT): New Perspectives on Advances in Treatment
0.25 credits
- Warner K. Huh, MD
  Peer
27
CME/CE
0.25 credits
Long-Term Efficacy & Safety of HPV Vaccination
0.25 credits
- Sara Hurvitz, MD
  Peer
- Tiffany Traina, MD
  Peer
9
CME/CE
0.25 credits
Advancements in Treatment Approaches for Triple-Negative Breast Cancer
0.25 credits
- Neilanjan Nandi
  Peer
- Millie D. Long, MD, MPH
  Peer
29
CME/CE
0.25 credits
New Perspectives on Biologic Therapy in Crohn’s Disease
0.25 credits
- Charles Geyer, MD
  Peer
3
CME/CE
0.25 credits
HER2+ Breast Cancer: Focus on the Adjuvant Setting
0.25 credits
3
FDA Drug Information Updates
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
- Shira Johnson, MD
  Peer
- Robert Vonderheide, MD
  Peer
24
Medical Breakthroughs from Penn Medicine
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

2/4